Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia.
Mwinga
Alwyn
A
Hosp
Maria
M
Zulu
Isaac
I
Farthing
Michael J G
MJ
Mulambo
Sylvia
S
Kelly
Paul
P
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003967:Diarrhea / Q000453:epidemiology / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D015994:Incidence; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use*; D012189:Retrospective Studies; D012293:Rifampin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000517:prevention & control*; D015024:Zambia / Q000453:epidemiology
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin